Rapid Acceleration of Diagnostics (RADx) Tech II Projects 13356 & 13464: Rapid, Point of Care, Multiplex COVID-19 and Flu A&B Antigen Assay and Reader
Award Notice Posted
- Solicitation number
- 75N92021C00027
- Agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Princeton Biomeditech Corp
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N92021C00027 Federal contract award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm-fixed price contract to Princeton Biomeditech Corporation for $10,000,000 on September 30, 2021. The contract was awarded under the authority of 41 U.S.C 253 (c)(1) to support the development of a rapid, point of care, multiplex COVID-19 and Flu A&B antigen assay and reader through projects 13356 & 13464 under the Rapid Acceleration of Diagnostics Tech II initiative.
Notice text
This acquisition was awarded under the authority of 41 U.S.C 253 ( c) (1) as set forth in FAR 6.302-3 industrial mobilization. A firm-fixed price type contract was awarded.
Awarded contract 75N92021C00027 to Princeton Biomeditech Corporation for 10100000.00 on 2021-09-30.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity